Prior authorization volumes are climbing and payer policies shift mid-year. Denial rates continue to rise across the industry. In that environment, the pull for revenue cycle teams is to pursue every new problem, respond to every escalation, chase every trend.…
The Latest
Vancouver, Wash.-based PeaceHealth has named Maureen Erbe system vice president of supply chain after more than three years leading supply chain operations for Kaiser Permanente’s Southern California and Hawaii markets, according to a Sept. 19 LinkedIn post. Ms. Erbe served…
Imagine naming every AI application running in your organization, what data each one touches, which permissions it holds and who authorized the last action it took. Most health systems cannot do this today, and adoption is moving faster than the…
Presented by:
Epic said its technology roadmap remains unchanged after CEO and founder Judy Faulkner disclosed the EHR vendor had paused most technology development to focus on cybersecurity. Ms. Faulkner told attendees at Modern Healthcare’s Leadership Summit that the pause involves hundreds…
Rockville Centre, N.Y.-based Catholic Health has named Michael Goleski system vice president of radiology. Mr. Goleski shared the move in a Sept. 22 LinkedIn post, saying he joined the Long Island organization to help advance radiology across the system. He…
CMS has advanced a range of coverage, payment and program integrity changes under President Donald Trump’s administration, including several major policies that have taken shape throughout 2026. The agency’s actions span Medicare and Medicaid payment reforms, ACA marketplace oversight, prior…
The FDA has issued a warning letter to Houston-based Empower Pharmacy after an inspection found evidence that certain compounded drugs failed to meet conditions for exemptions under federal law. The agency said Empower compounded products that appeared to be essentially…
Fresenius Medical Care is investigating a cybersecurity incident involving unauthorized access to a limited number of its internal systems. The incident has not affected the company’s medical devices, patient care, manufacturing operations or business continuity, according to a Sept. 22…
Off-label GLP-1 use increased fifteenfold between 2021 and 2025, according to a study published Sept. 22 in Obesity. Researchers analyzed medical records from more than 92 million U.S. adults to examine GLP-1 use among patients without a documented condition that…
The cell and gene therapy pipeline is no longer a distant possibility. It is arriving now, and health systems have a narrowing window to prepare. With more than 35 Food and Drug Administration-approved Cell and Gene Therapies (CGT) and a…